CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases

被引:69
作者
Lu, Qiang [1 ]
Cao, Wei [2 ]
Huang, Lijun [1 ]
Wan, Yi [3 ,4 ]
Liu, Tonggang [5 ]
Cheng, Qingshu [1 ]
Han, Yong [1 ]
Li, Xiaofei [1 ]
机构
[1] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Intervent Radiol, Xian 710032, Peoples R China
[3] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Peoples R China
[4] Fourth Mil Med Univ, Inst Hlth Informat, Xian 710032, Peoples R China
[5] Fourth Mil Med Univ, Tangdu Hosp, Dept Resp, Xian 710032, Peoples R China
关键词
Percutaneous microwave coagulation therapy; Inoperable pulmonary malignancies; Survival rates; RADIOFREQUENCY ABLATION; LUNG MALIGNANCIES; FOLLOW-UP; THERAPY; RESECTION; CANCER; LIVER;
D O I
10.1186/1477-7819-10-80
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Microwave ablation (MWA) has attracted a worldwide attention gradually in treating inoperable pulmonary malignancies. However, in the lung tissues treated with MWA recurrence of tumor may still occur and few data in large patient groups till now were reported about the safety or effectiveness of microwave ablation in treating primary lung cancer and metastatic pulmonary malignancies. The purpose of this study is to evaluate the clinical curative effect (local control, survival data) MWA and its safety as well. Methods: From 1 January 2005 to 1 January 2008, retrospective analyses, 69 patients underwent computed tomography (CT)-guided percutaneous MWA of pulmonary malignancies. All patients were deemed medically inoperable. The correlation of tumor sizes and local progression after ablation was analyzed and the survival rates within 3 years post surgery were compared between non-small-cell lung cancer and pulmonary metastases groups also. Results: Pneumothorax was the most frequent complication and occurred in 24.64% patients after ablation. Neither needle track implantation was found nor did patient death occur in these patients within 30 days. The 1-, 2-, and 3-year overall survival rates were 66.7%, 44.9% and 24.6%, respectively. The overall survival rates for NSCLC patients in 1 year, 2 years, and 3 years were 75.0%, 54.2%, and 29.2%, respectively. The overall survival rates for pulmonary metastatic tumor patients in 1 year, 2 years, and 3 years were 47.6%, 23.8%, and 14.3%, respectively. The recurrence-free survival rates for NSCLC patients in 1 year, 2 years, and 3 years were 72.9%, 50.0%, and 27.1%, respectively. The mortality rates for pulmonary metastatic tumor patients in 1 year, 2 years, and 3 years were 47.6%, 19.0%, and 14.3%, respectively. Conclusions: Percutaneous microwave coagulation therapy was one safe and effective method and could be beneficial for the improvement of inoperable pulmonary malignancies treatment effect.
引用
收藏
页数:7
相关论文
共 29 条
  • [1] Abbas Ghulam, 2007, Thorac Surg Clin, V17, P261, DOI 10.1016/j.thorsurg.2007.03.007
  • [2] [Anonymous], 2010, Common terminology criteria for adverse events, v4.03
  • [3] Primary Non-Small Cell Lung Cancer: Review of Frequency, Location, and Time of Recurrence after Radiofrequency Ablation
    Beland, Michael D.
    Wasser, Elliot J.
    Mayo-Smith, William W.
    Dupuy, Damian E.
    [J]. RADIOLOGY, 2010, 254 (01) : 301 - 307
  • [4] Tissue Contraction Caused by Radiofrequency and Microwave Ablation: A Laboratory Study in Liver and Lung
    Brace, Christopher L.
    Diaz, Teresa A.
    Hinshaw, J. Louis
    Lee, Fred T., Jr.
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2010, 21 (08) : 1280 - 1286
  • [5] Radiofrequency and Microwave Ablation of the Liver, Lung, Kidney, and Bone: What Are the Differences?
    Brace, Christopher L.
    [J]. CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY, 2009, 38 (03) : 135 - 143
  • [6] Microwave ablation therapy for treating primary and secondary lung tumours: technical note
    Carrafiello, G.
    Mangini, M.
    De Bernardi, I.
    Fontana, F.
    Dionigi, G.
    Cuffari, S.
    Imperatori, A.
    Lagana, D.
    Fugazzola, C.
    [J]. RADIOLOGIA MEDICA, 2010, 115 (06): : 962 - 974
  • [7] Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year:: Prospective evaluation
    de Baere, Thierry
    Palussiere, Jean
    Auperin, Anne
    Hakime, Antoine
    Abdel-Rehim, Mohamed
    Kind, Michele
    Dromain, Clarisse
    Ravaud, Alain
    Tebboune, Nathalie
    Boige, Valerie
    Malka, David
    Lafont, Clarisse
    Ducreux, Michel
    [J]. RADIOLOGY, 2006, 240 (02) : 587 - 596
  • [8] Resection of liver metastases is beneficial in patients with gastric cancer: report on 15 cases and review of literature
    Dittmar, Yves
    Altendorf-Hofmann, Annelore
    Rauchfuss, Falk
    Goetz, Max
    Scheuerlein, Hubert
    Jandt, Karin
    Settmacher, Utz
    [J]. GASTRIC CANCER, 2012, 15 (02) : 131 - 136
  • [9] Percutaneous radiofrequency ablation of malignancies in the lung
    Dupuy, DE
    Zagoria, RJ
    Akerley, W
    Mayo-Smith, WW
    Kavanagh, PV
    Safran, H
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 174 (01) : 57 - 59
  • [10] Evaluation of Treatment Response After Nonoperative Therapy for Early-Stage Non-Small Cell Lung Carcinoma
    Eradat, Jilbert
    Abtin, Fereidoun
    Gutierrez, Antonio
    Suh, Robert
    [J]. CANCER JOURNAL, 2011, 17 (01) : 38 - 48